Scarica l'app Stockscreener
0.671
3.44%
0.0223
Pre-mercato:
.67
-0.001
-0.15%
Precedente Chiudi:
$0.6487
Aprire:
$0.66
Volume 24 ore:
152.12K
Relative Volume:
0.22
Capitalizzazione di mercato:
$32.57M
Reddito:
$19.94M
Utile/perdita netta:
$-37.37M
Rapporto P/E:
-0.6452
EPS:
-1.04
Flusso di cassa netto:
$-33.38M
1 W Prestazione:
+18.89%
1M Prestazione:
+2.55%
6M Prestazione:
-50.66%
1 anno Prestazione:
-50.30%
Intervallo 1D:
$0.6481
$0.6889
Intervallo di 1 settimana:
$0.571
$0.7379
Portata 52W:
$0.5301
$2.38
Werewolf Therapeutics Inc Stock (HOWL) Company Profile
Nome
Werewolf Therapeutics Inc
Settore
Industria
Telefono
617-952-0555
Indirizzo
200 TALCOTT AVENUE, WATERTOWN
Confronta HOWL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HOWL
Werewolf Therapeutics Inc
|
0.671 | 31.49M | 19.94M | -37.37M | -33.38M | -1.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.17 | 120.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
771.25 | 80.15B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
864.42 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
354.75 | 47.74B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
336.16 | 37.38B | 4.98B | 69.59M | 525.67M | 0.5197 |
Werewolf Therapeutics Inc Stock (HOWL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-19 | Downgrade | Wedbush | Outperform → Neutral |
| 2024-04-03 | Iniziato | JMP Securities | Mkt Outperform |
| 2023-08-24 | Iniziato | Wedbush | Outperform |
| 2023-06-06 | Ripresa | Jefferies | Buy |
| 2021-09-10 | Iniziato | BofA Securities | Buy |
| 2021-05-25 | Iniziato | Evercore ISI | Outperform |
| 2021-05-25 | Iniziato | H.C. Wainwright | Buy |
| 2021-05-25 | Iniziato | Jefferies | Buy |
| 2021-05-25 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Werewolf Therapeutics Inc Borsa (HOWL) Ultime notizie
Evnin Luke, Werewolf Therapeutics director, sells $20,942 in Howl stock By Investing.com - Investing.com Nigeria
Evnin Luke, Werewolf Therapeutics director, sells $20,942 in Howl stock - Investing.com
Werewolf Therapeutics, Inc. (NASDAQ:HOWL) Short Interest Update - Defense World
Movement Recap: Can Black Hawk Acquisition Corporation ride the EV waveGlobal Markets & Growth Focused Entry Point Reports - baoquankhu1.vn
Werewolf Therapeutics (HOWL) price target decreased by 10.86% to 5.30 - MSN
Evenin Luke sells Werewolf Therapeutics (HOWL) stock for $61k By Investing.com - Investing.com Canada
Evenin Luke sells Werewolf Therapeutics (HOWL) stock for $61k - Investing.com
Luke Evnin Sells 24,678 Shares of Werewolf Therapeutics (NASDAQ:HOWL) Stock - Defense World
Growth Value: Can Werewolf Therapeutics Inc stock double in next 5 yearsPortfolio Performance Report & Expert Curated Trade Setup Alerts - Bộ Nội Vụ
Werewolf Therapeutics (HOWL) Eyes 2026 Catalysts Following FDA Guidance and Encouraging INDUKINE Results - Yahoo Finance
Evnin Luke sells Werewolf Therapeutics (HOWL) shares for $53,533 - Investing.com UK
Evnin Luke sells Werewolf Therapeutics (HOWL) shares for $53,533 By Investing.com - Investing.com Canada
Risk Analysis: Will Werewolf Therapeutics Inc. stock benefit from infrastructure spending2025 Technical Patterns & Daily Growth Stock Tips - Улправда
Is Werewolf Therapeutics Inc. stock ready for breakout2025 Growth vs Value & High Win Rate Trade Tips - ulpravda.ru
10 Stocks Under $1 That Will Explode - Insider Monkey
Werewolf Therapeutics (HOWL) upgraded to buy: Here's what you should know - MSN
Aug Analyst Calls: Can Werewolf Therapeutics Inc. stock hit analyst price targetsPortfolio Value Summary & Verified Technical Trade Signals - ulpravda.ru
How rising interest rates impact Werewolf Therapeutics Inc. stockJuly 2025 Opening Moves & Technical Analysis for Trade Confirmation - Улправда
Evnin Luke sells Werewolf Therapeutics (HOWL) stock for $45,882 - Investing.com UK
Evnin Luke sells Werewolf Therapeutics (HOWL) stock for $45,882 By Investing.com - Investing.com India
Luke Evnin Sells 34,847 Shares of Werewolf Therapeutics (NASDAQ:HOWL) Stock - Defense World
HOWL Stock Price, Forecast & Analysis | WEREWOLF THERAPEUTICS INC (NASDAQ:HOWL) - Chartmill
Will Werewolf Therapeutics Inc. stock return to pre crisis levelsAnalyst Upgrades & Capital Efficiency Improvement - bollywoodhelpline.com
Werewolf Therapeutics, Inc. (NASDAQ:HOWL) Receives Consensus Rating of “Hold” from Analysts - Defense World
Analysts Offer Insights on Healthcare Companies: Bristol-Myers Squibb (BMY) and Werewolf Therapeutics (HOWL) - The Globe and Mail
Market Moves: Is Werewolf Therapeutics Inc. stock ready for breakoutWeekly Trade Summary & Real-Time Stock Price Movement Reports - moha.gov.vn
Will Werewolf Therapeutics Inc. stock benefit from infrastructure spendingProduct Launch & Free Accurate Trade Setup Notifications - Улправда
Werewolf Therapeutics (NASDAQ:HOWL) Downgraded to “Neutral” Rating by Wedbush - Defense World
Why retail investors pile into Werewolf Therapeutics Inc. stockRisk Management & Technical Confirmation Trade Alerts - Улправда
HC Wainwright & Co. Maintains Werewolf Therapeutics (HOWL) Buy Recommendation - Nasdaq
H.C. Wainwright slashes Werewolf Therapeutics stock price target on pipeline update By Investing.com - Investing.com Nigeria
Can Werewolf Therapeutics Inc. stock hit analyst price targetsOil Prices & Capital Protection Trading Alerts - DonanımHaber
Wedbush Downgrades Werewolf Therapeutics to Neutral From Outperform Due to 'Forward Challenging' Path, Cuts Price Target to $1 From $3 - marketscreener.com
H.C. Wainwright slashes Werewolf Therapeutics stock price target on pipeline update - Investing.com Nigeria
Werewolf Therapeutics advances Inducer platform candidates - BioWorld MedTech
Werewolf Therapeutics Announces Pipeline and Business Updates - Investing News Network
Werewolf Therapeutics Updates Pipeline and Outlines 2026 Priorities - TipRanks
Werewolf Therapeutics Incplans for two INDs by mid-2027 - marketscreener.com
Werewolf Therapeutics, Inc. Announces Pipeline Update and 2026 Priorities - TradingView — Track All Markets
Werewolf Therapeutics Inc Azioni (HOWL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.09%
0.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):